Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.
about
Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesPrediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.Dysregulation of glucose metabolism in preclinical type 1 diabetes.Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.
P2860
Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hyperglycemic clamp and oral g ...... s of type 1 diabetic patients.
@en
Hyperglycemic clamp and oral g ...... s of type 1 diabetic patients.
@nl
type
label
Hyperglycemic clamp and oral g ...... s of type 1 diabetic patients.
@en
Hyperglycemic clamp and oral g ...... s of type 1 diabetic patients.
@nl
prefLabel
Hyperglycemic clamp and oral g ...... s of type 1 diabetic patients.
@en
Hyperglycemic clamp and oral g ...... s of type 1 diabetic patients.
@nl
P2093
P50
P921
P356
P1476
Hyperglycemic clamp and oral g ...... gs of type 1 diabetic patients
@en
P2093
Belgian Diabetes Registry
Christophe De Block
Evy Vandemeulebroucke
Johannes Ruige
Katelijn Decochez
Simke Demeester
Ursule Van De Velde
P304
P356
10.1210/JC.2014-2035
P407
P50
P577
2014-11-18T00:00:00Z